Prexa Pharmaceuticals Seals $7M
Boston-based Prexa Pharmaceuticals, which is developing therapies for central nervous system diseases and disorders, has closed on $7 million in Series B financing. Advent Healthcare Ventures led the round, which also included investment from Shire Pharmaceuticals. The money will help Prexa complete certain clinical studies. Prexa was formed in 2006, and previously raised $3.1 million in a first round.
11 May 2011•3 mins read
